𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignancies

✍ Scribed by Heinz Ludwig; David Khayat; Giuseppe Giaccone; Thierry Facon


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
177 KB
Volume
104
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The role of Src in solid and hematologic
✍ Ricardo H. Alvarez; Hagop M. Kantarjian; Jorge E. Cortes πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 327 KB

## Abstract __c‐Src__ was the first protooncogene described and was among the first molecules in which tyrosine kinase activity was documented. c‐Src has been defined as a common modular structure that participates in much of the crosstalk between the cytoplasmic protein tyrosine kinases and tyrosi

The role of clofarabine in hematologic a
✍ Stefan Faderl; Varsha Gandhi; Michael J. Keating; Sima Jeha; William Plunkett; H πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 190 KB

## Abstract Clofarabine is a new‐generation nucleoside analog that has been synthesized to combine the most favorable pharmacokinetic properties of its congeners fludarabine and cladribine. In addition to inhibition of DNA polymerases and DNA synthesis, clofarabine acts as a strong inhibitor of rib

Clinical implications of the tumor necro
✍ Anas Younes; Bharat B. Aggarwall πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 190 KB

## Abstract Tumor necrosis factor (TNF), originally identified as a factor produced in the serum of endotoxin‐injected animals, is a cytokine that mediates tumor necrosis. To date, 20 different members of the TNF superfamily and 21 different receptors have been identified. All ligands of the TNF su